Information available on our website about this product is for educational purposes only and should not be interpreted as an endorsement or directive for use outside these bounds
Injection-site and systemic risks : Improper reconstitution or non-sterile technique can introduce bacteria or particulates into the solution, leading to localised infections, abscesses, or, in severe cases, systemic sepsis
After taking semaglutide for 68 weeks, the average participant lost more than 15 percent of their body weight
In large RCTs, patients receiving semaglutide, 2.4 mg, lost a mean of 6% of their weight by week 12 and 12% of their weight by week 28. (Source) It is important to note that GLP-1 is not a magic bullet for weight loss and should not be used as a substitute for a healthy lifestyle
If you are using or stopping a GLP-1 medication, nutrition and lifestyle support matter